Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer

Promoter hypermethylation, a widely studied epigenetic event known to influence gene expression levels, has been proposed as a potential biomarker in multiple types of cancer. Clinical diagnostic biomarkers are needed for reliable prediction of bladder cancer recurrence. In this paper, DNA promoter...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Wei, Huebner, Alexander, Shabsigh, Ahmad, Chakravarti, Arnab, Lautenschlaeger, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316979/
https://www.ncbi.nlm.nih.gov/pubmed/22530128
http://dx.doi.org/10.1155/2012/701814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316979/
https://www.ncbi.nlm.nih.gov/pubmed/22530128
http://dx.doi.org/10.1155/2012/701814

Ejemplares similares